ABT vs IRM · P/E 25, rev $44.33B vs P/E 136, rev $3.97B
Abbott Laboratories (ABT) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the ABT and IRM stock pages for the full models.
Not investment advice.